From the ∗Department of Medical Microbiology, Infectious Diseases & Infection Prevention, Maastricht University Medical Center, Care and Public Health Research Institute (CAPHRI), Maastricht
†Department of Sexual Health, Infectious Diseases and Environmental Health, Public Health Service South Limburg, Heerlen
‡Department Health Promotion
§Department Social Medicine, Maastricht University, Care and Public Health Research Institute (CAPHRI), Maastricht, the Netherlands
Acknowledgments: The authors thank the staff of the STI Clinic South Limburg and the Dutch Chlamydia Screening Implementation (CSI) project group JEAM van Bergen, IVF van den Broek, EEHG Brouwers, CJPA Hoebe, JSA Fennema, RH Koekenbier, ELM Op de Coul, LL Pars and SM van Ravesteijn for their valuable contribution to the CSI sample collection.
Conflict of Interest and Sources of Funding: None declared.
Ethics statement: The Medical Ethics Committee of the Maastricht University Medical Center+ approved this study and waived the need for additional informed consent (METC 13-4-026).
Author Contributions: All authors contributed to the research conception and design. Material preparation, data collection and analysis were performed by J.A.M.C.D., I.H.M.v.L., and N.H.T.M.D.-M. The first draft of this manuscript was written by J.A.M.C.D., and all authors commented on previous versions of the manuscript. All authors read and approved the final article.
Correspondence: Jeanne A.M.C. Dirks, MD, PhD, Department of Medical Microbiology, Infectious diseases and Infection prevention, Maastricht University Medical Center+ (MUMC+), PO box 5800, 6202 AZ Maastricht, The Netherlands. E-mail: [email protected].
Received for publication October 4, 2022, and accepted November 30, 2022.
